<p>Base-case results from population of 50,000, with 3% annual discounting of effects.</p>a<p>Costs for international consultants excluded;</p>b<p>Costs of vaccination program minus public COI averted by vaccination (cost savings);</p><p>YLD: Years of life lived with disability, YLL: Years of life lost, DALY: Disability-adjusted life-year, ICER: Incremental cost-effectiveness ratio.</p
ABSTRACTObjectivesWe evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and use...
The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. W...
IntroductionIn 2016, for the very first time, the Ministry of Health in Zambia implemented a reactiv...
Background: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplem...
a<p>Total costs (2009 USD) to vaccinate a target population of 49,980 people;</p>b<p>Mean costs (200...
BACKGROUND:Cholera causes an estimated 100,000 deaths annually worldwide, with the majority of burde...
BACKGROUND:Cholera remains an important public health problem in major cities in Bangladesh, especia...
BackgroundCholera remains an important public health problem in major cities in Bangladesh, especial...
Incremental cost-effectiveness ratios (cost per DALY averted) for vaccination of 1–14 year olds with...
Objectives: We evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and used in V...
Killed, oral cholera vaccines have proven safe and effective, and several large-scale mass cholera v...
<p>3a: During the 2006–07 outbreak in Unguja following a <u>rapid</u> mass oral cholera vaccine camp...
Killed oral cholera vaccines (OCVs) have been licensed for use in developing countries, but protecti...
BACKGROUND: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority...
BACKGROUND: Cholera remains an important public health problem in major cities in Bangladesh, especi...
ABSTRACTObjectivesWe evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and use...
The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. W...
IntroductionIn 2016, for the very first time, the Ministry of Health in Zambia implemented a reactiv...
Background: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplem...
a<p>Total costs (2009 USD) to vaccinate a target population of 49,980 people;</p>b<p>Mean costs (200...
BACKGROUND:Cholera causes an estimated 100,000 deaths annually worldwide, with the majority of burde...
BACKGROUND:Cholera remains an important public health problem in major cities in Bangladesh, especia...
BackgroundCholera remains an important public health problem in major cities in Bangladesh, especial...
Incremental cost-effectiveness ratios (cost per DALY averted) for vaccination of 1–14 year olds with...
Objectives: We evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and used in V...
Killed, oral cholera vaccines have proven safe and effective, and several large-scale mass cholera v...
<p>3a: During the 2006–07 outbreak in Unguja following a <u>rapid</u> mass oral cholera vaccine camp...
Killed oral cholera vaccines (OCVs) have been licensed for use in developing countries, but protecti...
BACKGROUND: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority...
BACKGROUND: Cholera remains an important public health problem in major cities in Bangladesh, especi...
ABSTRACTObjectivesWe evaluated the cost-effectiveness of a low-cost cholera vaccine licensed and use...
The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. W...
IntroductionIn 2016, for the very first time, the Ministry of Health in Zambia implemented a reactiv...